Chemical Structure (Lamotrigine Orally Disintegrating Tablets 1)
Lamotrigine Tablet, Orally Disintegrating
Product Images NDC 0115-1528
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 0115-1528). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Mood Episode (trial 1) (Lamotrigine Orally Disintegrating Tablets 2)
This is a graph showing the failure probability percentage for the drug Lamotrigine over a course of several weeks. The percentage is indicated on the y-axis while the weeks are indicated on the x-axis. There is a censor indicated in the graph.*
Figure 2 Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Mood Episode (trial 2) (Lamotrigine Orally Disintegrating Tablets 3)
This is a report related to the failure probability of certain medication measured in weeks. However, the information is not complete, as there is no available context or explanation on what "Censored TR" means.*
Lamotrigine Orally Disintegrating Tablets (Lamotrigine Orally Disintegrating Tablets 4)
The text describes tablets in different strengths, 25mg, 50mg, 100mg, and 200mg, that are off-white to white in color. Each tablet is marked with "WPI" on one side and a different number, either 3721, 3722, 3723, or 3724, on the other side.*
Principal Display Panel (25 mg Tablet Blister Pack Carton)
This is a description of a pharmaceutical product called "Lamotrigine Orally Disintegrating Tablets", containing 30 25mg tablets in two blisters. The description provides the National Drug Code (NDC) and warns about the presence of Phenylalanine, advising to verify the product before dispensing. The recommended storage temperature is between 20°C to 25°C. The text includes some unclear characters, but the has done a good job in providing most of the crucial information.*
Principal Display Panel (50 mg Tablet Blister Pack Carton)
The given text seems to contain a mix of random characters, symbols, and some English words related to Lamotrigine Orally Disintegrating Tablets. It is not a complete, recognizable description of the product.*
Principal Display Panel (100 mg Tablet Blister Pack Carton)
This is a description of a medication called Lamotrigine. It comes in orally-disintegrating tablets of 100mg and is packaged with 30 tablets per package - 3 blisters of 10. The tablets contain Lamotrigine USP, and the usual dosage can be found in the prescribing information. The medication must be stored between 20°C and 25°C and comes from India. The package has a warning to keep it out of reach of children, and pharmacists must dispense with a medication guide. There is also caution that the medication contains Phenylalanine 5.60 my per tablet.*
Principal Display Panel (200 mg Tablet Blister Pack Carton)
This document appears to be a mix of different texts. The first part is not readable, while the second part is a description of Lamotrigine Orally Disintegrating Tablets, with their dosage, packaging, and storage information. It also contains a warning about the presence of Phenylalanine and advises to keep it out of reach of children. The last line may contain a reference number or a code.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
